Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $337.23 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $188.60 | 3 | $0 (2024) |
| Puma Biotechnology, Inc. | $41.85 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $26.97 | 1 | $0 (2023) |
| Amgen Inc. | $26.88 | 2 | $0 (2019) |
| Cardinal Health 414 LLC | $21.90 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $18.69 | 1 | $0 (2021) |
| Foundation Medicine, Inc. | $12.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.16 | 2 | AstraZeneca Pharmaceuticals LP ($57.16) |
| 2023 | $171.62 | 3 | AstraZeneca Pharmaceuticals LP ($131.44) |
| 2021 | $31.03 | 2 | Novartis Pharmaceuticals Corporation ($18.69) |
| 2020 | $50.54 | 2 | Puma Biotechnology, Inc. ($28.64) |
| 2019 | $14.79 | 1 | Amgen Inc. ($14.79) |
| 2017 | $12.09 | 1 | Amgen Inc. ($12.09) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Oncology | ||||||
| 01/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Oncology | ||||||
| 06/09/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $131.44 | General |
| Category: Oncology | ||||||
| 04/13/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $13.21 | General |
| 06/03/2021 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2021 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2020 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2020 | Cardinal Health 414 LLC | Lymphoseek (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Hematology Oncology | ||||||
| 10/24/2019 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Oncology | ||||||
| 02/28/2017 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 4,963 | 50,808 | $2.7M | $349,362 |
| 2022 | 54 | 3,828 | 52,645 | $2.5M | $314,916 |
| 2021 | 58 | 3,068 | 27,736 | $1.6M | $236,451 |
| 2020 | 55 | 2,710 | 13,646 | $1.2M | $193,539 |
All Medicare Procedures & Services
287 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 321 | 335 | $384,709 | $49,110 | 12.8% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 224 | 225 | $246,599 | $22,532 | 9.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 100 | 101 | $175,661 | $22,216 | 12.6% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 145 | 149 | $171,930 | $21,776 | 12.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 437 | 437 | $76,330 | $16,219 | 21.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 81 | 86 | $185,502 | $14,248 | 7.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 113 | 113 | $176,714 | $13,323 | 7.5% |
| 73718 | Mri scan of leg without contrast | Office | 2023 | 68 | 73 | $82,812 | $12,795 | 15.5% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 49 | 49 | $94,580 | $12,644 | 13.4% |
| 77067 | Screening mammography | Office | 2023 | 101 | 101 | $23,028 | $12,479 | 54.2% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 65 | 65 | $50,636 | $8,741 | 17.3% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 121 | 123 | $81,094 | $8,685 | 10.7% |
| 73700 | Ct scan of leg without contrast | Office | 2023 | 75 | 79 | $63,200 | $7,367 | 11.7% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 40 | 42 | $90,291 | $7,013 | 7.8% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 65 | 67 | $16,281 | $5,919 | 36.4% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 50 | 50 | $15,650 | $5,514 | 35.2% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 97 | 97 | $35,984 | $5,343 | 14.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 101 | 101 | $13,130 | $5,213 | 39.7% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 50 | 50 | $57,115 | $4,955 | 8.7% |
| 73218 | Mri scan of arm without contrast | Office | 2023 | 21 | 22 | $25,146 | $4,886 | 19.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 107 | 109 | $14,170 | $4,394 | 31.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 64 | 64 | $18,536 | $4,132 | 22.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 178 | 179 | $22,183 | $4,059 | 18.3% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 49 | 49 | $47,147 | $3,960 | 8.4% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 41 | 41 | $47,320 | $3,960 | 8.4% |
About Dr. Stephen Sevigny, M.D
Dr. Stephen Sevigny, M.D is a Nuclear Radiology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326082975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Sevigny, M.D has received a total of $337.23 in payments from pharmaceutical and medical device companies, with $57.16 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($337.23).
As a Medicare-enrolled provider, Sevigny has provided services to 14,569 Medicare beneficiaries, totaling 144,835 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 287 distinct procedure/service records.
Practice Information
- Specialty Nuclear Radiology
- Other Specialties Therapeutic Radiology, Vascular & Interventional Radiology
- Location Gainesville, GA
- Active Since 06/15/2006
- Last Updated 11/18/2025
- Taxonomy Code 2085N0904X
- Entity Type Individual
- NPI Number 1326082975
Products in Payments
- IMFINZI (Biological) $159.40
- ENHERTU (Biological) $29.20
- NERLYNX (Drug) $28.64
- Enhertu (Drug) $26.97
- Lymphoseek (Drug) $21.90
- PIQRAY (Drug) $18.69
- Kyprolis (Biological) $14.79
- FOUNDATIONONE (Device) $12.34
- Neulasta (Biological) $12.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Radiology Doctors in Gainesville
Dr. Michael Schiering, Md, MD
Nuclear Radiology — Payments: $502.37
Gilbert Daniel, Md, MD
Nuclear Radiology — Payments: $24.42
Walter Drane, Md, MD
Nuclear Radiology
Suzanne Mastin, Md, MD
Nuclear Radiology
Dr. Aman Mehan, Md, MD
Nuclear Radiology